(The Hill) – The Food and Drug Administration (FDA) is opening the way for more cancer drugs from China as the U.S. continues to deal with an ongoing shortage in key chemotherapy treatments.
The U.S. branch of India’s Sun Pharma issued a voluntary recall of more than 55,000 bottles of febuxostat tablets used to treat gout after a report of microbial contamination in the company's ...
Shares of Sun Pharmaceutical Industries rose around 2 percent and hit a 52-week high of Rs 1,606.75 on March 6 afternoon after the US Food and Drugs Administration reportedly gave the company's ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...
The patent on Revlimid expires in January 2026 and the three pharma majors, which have seen strong growth on the back of this drug, are looking for other opportunities to keep their growth path.
Seamless reading experience. Save your favourite. Though India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for ...
Links to learn more about the FDA's import ban on widely used generic drugs. Sept. 16, 2008— -- The Food and Drug Administration announced today that it will block the import of some widely ...
"As we achieve formidable positions in many markets, our strategy now entails enhancing focus on select countries from our geographical presence, which promises high growth potential," Ajanta ...
The Central Drugs Standard Control Organisation (CDSCO) has declared almost 5 per cent of the total drug samples it tested during the month of January, 2024 as Not of Standard Quality (NSQ). The ...